The stock has a 36-month beta value of 0.92. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 3 as “sell.”
The public float for SKIN is 77.34M, and at present, short sellers hold a 11.00% of that float. On November 13, 2024, the average trading volume of SKIN was 1.06M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SKIN) stock’s latest price update
Beauty Health Company (NASDAQ: SKIN) has experienced a decline in its stock price by -1.18 compared to its previous closing price of 1.70. However, the company has seen a gain of 0.60% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that The Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja – Investor Relations Marla Beck – President and CEO Mike Monahan – CFO Conference Call Participants Oliver Chen – TD Cowen Ashley Helgans – Jefferies Allen Gong – JPMorgan Susan Anderson – Canaccord Genuity Bruce Jackson – Benchmark Company Jon Block – Stifel Linda Bolton Weiser – DA Davidson Korinne Wolfmeyer – Piper Sandler Olivia Tong – Raymond James Operator Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode.
SKIN’s Market Performance
Beauty Health Company (SKIN) has experienced a 0.60% rise in stock performance for the past week, with a 3.07% rise in the past month, and a 20.00% rise in the past quarter. The volatility ratio for the week is 10.34%, and the volatility levels for the past 30 days are at 7.85% for SKIN. The simple moving average for the last 20 days is 0.04% for SKIN’s stock, with a simple moving average of -29.48% for the last 200 days.
Analysts’ Opinion of SKIN
Many brokerage firms have already submitted their reports for SKIN stocks, with Jefferies repeating the rating for SKIN by listing it as a “Hold.” The predicted price for SKIN in the upcoming period, according to Jefferies is $1.50 based on the research report published on November 15, 2023 of the previous year 2023.
SKIN Trading at 7.25% from the 50-Day Moving Average
After a stumble in the market that brought SKIN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.50% of loss for the given period.
Volatility was left at 7.85%, however, over the last 30 days, the volatility rate increased by 10.34%, as shares sank -1.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.37% lower at present.
During the last 5 trading sessions, SKIN fell by -4.19%, which changed the moving average for the period of 200-days by -48.05% in comparison to the 20-day moving average, which settled at $1.6753. In addition, Beauty Health Company saw -45.98% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SKIN starting from SAUNDERS BRENT L, who purchase 40,450 shares at the price of $1.08 back on Aug 12 ’24. After this action, SAUNDERS BRENT L now owns 5,921,769 shares of Beauty Health Company, valued at $43,686 using the latest closing price.
Stock Fundamentals for SKIN
Current profitability levels for the company are sitting at:
- -0.38 for the present operating margin
- 0.33 for the gross margin
The net margin for Beauty Health Company stands at -0.23. The total capital return value is set at -0.22. Equity return is now at value -72.45, with -9.74 for asset returns.
Based on Beauty Health Company (SKIN), the company’s capital structure generated 0.89 points at debt to capital in total, while cash flow to debt ratio is standing at 0.0. The debt to equity ratio resting at 8.02. The interest coverage ratio of the stock is -11.36.
Currently, EBITDA for the company is -91.48 million with net debt to EBITDA at -2.17. When we switch over and look at the enterprise to sales, we see a ratio of 1.2. The receivables turnover for the company is 7.21for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.49.
Conclusion
To sum up, Beauty Health Company (SKIN) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
